Síndrome post-covid, manifestaciones clínicas, diagnóstico y tratamiento, una revisión bibliográfica desde enero 2020 hasta enero 2022

Abstract

SARS-CoV-2 (severe acute respiratory syndrome coronavirus type 2), the causative agent of coronavirus disease 2, which has been responsible for a pandemic (COVID-19) that occurred in early 2019 and has since caused a global health crisis, a huge burden on the healthcare resources of every country, and above all, has been the cause of millions of deaths worldwide. While increasing the number of people recovering from COVID-19, it is essential to determine the health consequences related to them. Today, COVID-19 is categorized as a disease involving various organs and systems in the human body with uncertain predictability of health status and variability of manifestations, similar to other viral syndromes that have been reported in past years described by survivors of other virulent epidemics, causing more and more persistent and long-term sequelae to be reported following COVID-19. Patient advocacy groups whose members are considered long-term survivors have been successful in gaining recognition for acute POST-COVID- 19 syndrome, or "long-term COVID" or "long COVID" disease characterized by the presence of persistent symptoms and/or complications that may last for more than one month after the appearance of symptoms. Immediately, we provide accurate information based on the updated literature review on POST-COVID-19 syndrome, etiology, pathophysiology and clinical manifestations presented by this disease. To conclude, we will discuss aspects relevant to multidisciplinary care for those survivors of COVID 19, presenting a framework for identifying and managing high-risk individuals with acute POST-COVID-19 syndrome, based on recently published peer-reviewed articles.